Open Journal of Depression
Vol.3 No.3(2014), Paper ID 48963, 12
pages
DOI:10.4236/ojd.2014.33015
Does Early Improvement in Anxiety Symptoms in Patients with Major Depressive Disorder Affect Remission Rates? A Post-Hoc Analysis of Pooled Duloxetine Clinic Trials
Murat Altin, Eiji Harada, Alexander Schacht, Lovisa Berggren, Daniel Walker, Hector Dueñas
Eli Lilly-Turkey, Istanbul, Turkey
Lilly Research Laboratories Japan, Eli Lilly Japan K.K., Kobe, Japan
Eli Lilly and Company, Health Technology Appraisal Group, Bad Homburg, Germany
Eli Lilly and Company, Health Technology Appraisal Group, Bad Homburg, Germany
Lilly USA, LLC, Indianapolis, USA
Eli Lilly de México, Mexico City, Mexico
Copyright © 2014 Murat Altin, Eiji Harada, Alexander Schacht, Lovisa Berggren, Daniel Walker, Hector Dueñas et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Altin, M. , Harada, E. , Schacht, A. , Berggren, L. , Walker, D. and Dueñas, H. (2014) Does Early Improvement in Anxiety Symptoms in Patients with Major Depressive Disorder Affect Remission Rates? A Post-Hoc Analysis of Pooled Duloxetine Clinic Trials.
Open Journal of Depression,
3, 112-123. doi:
10.4236/ojd.2014.33015.